Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZOLMITRIPTAN, with a corresponding US DMF Number 25297.
Remarkably, this DMF maintains an Active status since its submission on September 13, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2013, and payment made on September 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II